← Back to Clinical Trials
Recruiting NCT06029062

NCT06029062 tACS for Sensory Motor Recovery After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06029062
Status Recruiting
Phase
Sponsor The University of Texas Health Science Center, Houston
Condition Motor Recovery
Study Type INTERVENTIONAL
Enrollment 14 participants
Start Date 2025-09-01
Primary Completion 2027-09-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
tACS ShamtACS 10HztACS 20Hz

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 14 participants in total. It began in 2025-09-01 with a primary completion date of 2027-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall goal is to investigate the effectiveness of a novel intervention - transcranial alternating current stimulation (tACS) for motor recovery in stroke survivors.

Eligibility Criteria

Inclusion/exclusion criteria for stroke subjects Inclusion criteria: 1. Age between 18\~75 years old 2. ≥ 6 months post stroke, medically stable; 3. Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); 4. Visible finger flexor activation/movement 5. The ability to give consent Exclusion criteria: 1. Patients with visual deficit/neglect; hearing or cognitive impairment; 2. Patients that are currently adjusting tone alternating medications (e.g., baclofen), or 3. Patients received botulinum toxin injection to the arm/fingers \<4 months, or phenol injections \<2 years; 4. Patients with pacemaker, metal implants or supplemental oxygen; 5. Patients who have musculoskeletal disorders, including pain in the affected side 6. Women who are pregnant.

Contact & Investigator

Central Contact

Sheng Li, MD, Ph.D

✉ sheng.li@uth.tmc.edu

📞 (713) 797-7125

Principal Investigator

Sheng Li, MD, Ph.D

PRINCIPAL INVESTIGATOR

The University of Texas Health Science Center, Houston

Frequently Asked Questions

Who can join the NCT06029062 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Motor Recovery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06029062 currently recruiting?

Yes, NCT06029062 is actively recruiting participants. Contact the research team at sheng.li@uth.tmc.edu for enrollment information.

Where is the NCT06029062 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT06029062 clinical trial?

NCT06029062 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Sheng Li, MD, Ph.D at The University of Texas Health Science Center, Houston. The trial plans to enroll 14 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology